On October 2, 2020 Kineta, Inc., a clinical stage biotechnology company focused on the development of novel immunotherapies in oncology, neuroscience and biodefense reported that Kineta will be participating in the BIO Investor Forum Digital on October 13-15, 2020 (Press release, Kineta, OCT 2, 2020, View Source;utm_medium=rss&utm_campaign=kineta-to-participate-in-bio-investor-forum-digital [SID1234567970]). Shawn Iadonato, Kineta Chief Executive Officer and Jacques Bouchy, SVP Business Development and Corporate Communications will be meeting with investors and other stakeholders to present an overview of the company with a focus on its novel VISTA immuno-oncology program.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
About BIO Investor Forum Digital
BIO Investor Forum Digital, October 13-15, provides three days of enhanced BIO One-on-One Partnering, interactive educational sessions and Fireside Chats and 160 on-demand company presentations showcasing their drug development programs ready for partnering or venture funding. There is no better virtual event for biotech innovators looking for investors and strategic partners to advance their company to the next stage in their business life cycle. Visit bio.org/investor forum to learn more.